Decoy receptor 3 expression in esophageal squamous cell carcinoma: Correlation with tumour invasion and metastasis

Biomarkers

Volumn 16, Issue 2, 2011, Pages 155-160

  Xiong, Gang ^a   Guo, Hong ^a   Ge, Xiaodong ^a   Xu, Xueqing ^a   Yang, Xiaoya ^a   Yang, Kang ^a   Jiang, Yaoguang ^b   Bai, Yun ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Decoy receptor 3 (DcR3); esophageal squamous cell carcinoma (ESCC); invasion; metastasis

Indexed keywords

DECOY RECEPTOR 3; MESSENGER RNA; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER TISSUE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE OVEREXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC ASSOCIATION STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDIES; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 6B; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOLUBILITY; TUMOR MARKERS, BIOLOGICAL;

EID: 79951941094     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2010.536258     Document Type: Article

References (25)

1. Bai C, Connolly B, Metzker ML, et al. (2000) Overexpression of M68/ DcR3 in human gastrointestinal tract tumors independent of gene amplification and its location in a four-gene cluster. PNAS 97:1230-1235. (Pubitemid 30080841)
2. Brown LM, Hoover R, Silverman D, et al. (2001) Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am J Epidemiol 153:114-122. (Pubitemid 32063186)
3. Chang YC, Chan YH, Jackson DG, et al. (2006) The glycosaminoglycan- binding domain of decoy receptor 3 is essential for induction of monocyte adhesion. J Immunol. (Baltimore, Md: 1950) 176:173-180. (Pubitemid 43023261)
4. Chang YC, Hsu TL, Lin HH, et al. (2004) Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol 75:486-494.
5. Enzinger PC, Mayer RJ. (2003) Esophageal cancer. N Engl J Med 349:2241-52. (Pubitemid 37485141)
6. Greene FL, Page DL, Fleming ID, et al. (2002) AJCC Cancer Staging Manual. 6th Edition. New York: Springer.
7. Hsu TL, Chang YC, Chen SJ, et al. (2002) Modulation of dendritic cell differentiation and maturation by decoy receptor 3. J Immunol(Baltimore, Md: 1950) 168:4846-4853.
8. Jemal A, Siegel R, Ward E, et al. (2008) Cancer statistics. CA Cancer J Clin 58:71-96.
9. Kamangar F, Dores GM, Anderson WF. (2006) Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 24:2137-2150. (Pubitemid 46655601)
10. Macher-Goeppinger S, Aulmann S, Wagener N, et al. (2008) Decoy receptor 3 is a prognostic factor in renal cell cancer. Neoplasia 10:1049-1056.
11. Migone TS, Zhang J, Luo X, et al. (2002) TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity 16:479-492. (Pubitemid 34260924)
12. Ohshima K, Haraoka S, Sugihara M, et al. (2000) Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett 160:89-97.
13. Pickens A, Orringer MB. (2003) Geographical distribution and racial disparity in esophageal cancer. Ann Thorac Surg 76:S1367-1369 (Pubitemid 37204779)
14. Pitti RM, Marsters SA, Lawrence DA, et al. (1998) Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature 396:699-703. (Pubitemid 29003951)
15. Roth W, Isenmann S, Nakamura M, et al. (2001) Soluble decoy receptor 3 is expressed by malignant gliomas and suppresses CD95 ligandinduced apoptosis and chemotaxis. Cancer Res 61:2759-2765. (Pubitemid 32685866)
16. Shi G, Wu Y, Zhang J, et al. (2003) Death decoy receptor TR6/DcR3 inhibits T cell chemotaxis in vitro and in vivo. J Immunol. (Baltimore, Md: 1950) 171:3407-3414. (Pubitemid 37254541)
17. Simon I, Liu Y, Krall KL, et al. (2007) Evaluation of the novel serum markers B7-H4, Spondin 2, and DcR3 for diagnosis and early detection of ovarian cancer. Gynecol Oncol 106: 112-118. (Pubitemid 46898578)
18. Stoner GD, Gupta A. (2001) Etiology and chemoprevention of esophageal squamous cell carcinoma. Carcinogenesis 22:1737-46. (Pubitemid 33064837)
19. Takahama Y, Yamada Y, Emoto K, et al. (2002) The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas. Gastric Cancer 5:61-68. (Pubitemid 34832239)
20. Tsuji S, Hosotani R, Yonehara S, et al. (2003) Endogenous decoy receptor 3 blocks the growth inhibition signals mediated by Fas ligand in human pancreatic adenocarcinoma. Int J Cancer 106:17-25. (Pubitemid 36750383)
21. Wan X, Shi G, Semenuk M, et al. (2003) DcR3/TR6 modulates immune cell interactions. J Cell Biochem 89:603-612. (Pubitemid 36648781)
22. Wu Y, Guo E, Yu J, et al. (2008) High DcR3 expression predicts stage pN2-3 in gastric cancer. Am J Clin Oncol 31: 79-83.
23. Wu Y, Han B, Sheng H, et al. (2003) Clinical significance of detecting elevated serum DcR3/TR6/M68 in malignant tumor patients. Int J Cancer 105:724-732. (Pubitemid 36687744)
24. Yu KY, Kwon B, Ni J, et al. (1999) A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHTmediated apoptosis. J Biol Chem 274:13733-13736.
25. Zhang J, Salcedo TW, Wan X, et al. (2001) Modulation of T-cell responses to alloantigens by TR6/DcR3. J Clin Invest 107:1459-1468. (Pubitemid 32522040)